MannKind Corp reports results for the quarter ended March 31 - Earnings Summary

• MannKind Corp MNKD.OQ reported quarterly adjusted earnings of 4 cents​​ per share for the quarter ended March 31, identical to the same quarter last year. The mean expectation of five analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from 3 cents to 5 cents per share.

• Revenue rose 18.2% to $78.35 million from a year ago; analysts expected $76.13 million.

• MannKind Corp's reported EPS for the quarter was 4 cents​.

• The company reported quarterly net income of $13.16 million.

• MannKind Corp shares had fallen by 3.6% this quarter and lost 24.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 46.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for MannKind Corp is $10.00

This summary was machine generated from LSEG data May 8 at 02:14 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)